Exact Sciences Corporation (EXAS)

Exact Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	956	600.89	605.38	242.49	315.47
Short-Term Investments	8.72	437.14	172.27	389.56	715.01
Cash & Short-Term Investments	964.71	1,038	777.64	632.06	1,030
Cash Growth	-7.06%	33.48%	23.03%	-38.66%	-43.99%
Receivables	298.65	248.97	203.62	158.04	216.65
Inventory	166.2	162.38	127.48	118.26	104.99
Prepaid Expenses	96.48	94.15	85.63	73.6	74.12
Restricted Cash	-	-	-	0.3	-
Other Current Assets	29.8	27.9	-	-	-
Total Current Assets	1,556	1,571	1,194	982.26	1,426
Property, Plant & Equipment	842.1	830.43	853.36	861.96	772.67
Long-Term Investments	62.78	57.94	51.17	43.74	26.8
Goodwill	2,368	2,367	2,367	2,346	2,335
Other Intangible Assets	919.93	1,010	1,890	1,956	2,094
Long-Term Accounts Receivable	-	25.9	41.7	-	-
Other Long-Term Assets	111.93	66.09	73.22	36.64	29.59
Total Assets	5,861	5,928	6,471	6,227	6,685

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	175.87	89.57	78.82	74.92	67.83
Accrued Expenses	388.79	305.96	324.52	284.75	372.68
Current Portion of Long-Term Debt	-	249.15	50	-	-
Current Portion of Leases	39.88	35.21	33.78	31.57	25.91
Current Unearned Revenue	-	-	-	-	1
Other Current Liabilities	36.62	52.3	27.59	21.51	49.65
Total Current Liabilities	641.15	732.19	514.7	412.75	517.07
Long-Term Debt	2,327	2,321	2,314	2,236	2,180
Long-Term Leases	167.78	170.33	168.57	189.8	194.67
Long-Term Deferred Tax Liabilities	5.8	-	-	-	-
Other Long-Term Liabilities	317.67	302.3	328.48	345.06	405.28
Total Liabilities	3,460	3,526	3,326	3,184	3,297

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.91	1.86	1.82	1.78	1.74
Additional Paid-In Capital	7,103	6,899	6,611	6,312	6,029
Retained Earnings	-4,706	-4,498	-3,469	-3,265	-2,642
Comprehensive Income & Other	2.36	-0.94	1.43	-5.24	-1.44
Shareholders' Equity	2,401	2,402	3,145	3,043	3,388
Total Liabilities & Equity	5,861	5,928	6,471	6,227	6,685

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,535	2,776	2,567	2,457	2,401
Net Cash (Debt)	-1,570	-1,738	-1,789	-1,825	-1,370
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-8.32	-9.43	-9.93	-10.35	-8.00
Filing Date Shares Outstanding	190.89	185.76	181.53	178.22	174.12
Total Common Shares Outstanding	190.8	185.62	181.36	177.93	173.67
Working Capital	914.7	839.24	679.67	569.51	909.17
Book Value Per Share	12.58	12.94	17.34	17.10	19.51
Tangible Book Value	-886.92	-974.12	-1,112	-1,259	-1,042
Tangible Book Value Per Share	-4.65	-5.25	-6.13	-7.08	-6.00
Land	4.72	4.72	4.72	4.72	4.72
Buildings	290.78	290.78	290.78	288.94	210.56
Machinery	668.91	583.06	494.18	423.29	327.16
Construction In Progress	84.14	89.07	104.59	68.4	100.34
Leasehold Improvements	257.5	227.89	214.56	200.59	147.08

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error